Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP/PKA Signaling Pathway in Rats with Parkinson’s Disease
Author(s) -
DongMei Wu,
Shan Wang,
Xin Wen,
XinRui Han,
YongJian Wang,
Min Shen,
ShaoHua Fan,
Juan Zhuang,
Zi-Feng Zhang,
Qun Shan,
MengQiu Li,
Bin Hu,
Chunhui Sun,
Jun Lü,
YuanLin Zheng
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000495649
Subject(s) - homovanillic acid , tyrosine hydroxylase , dopamine receptor d2 , dopamine , glutathione peroxidase , creb , chemistry , tunel assay , dopaminergic , striatum , endocrinology , medicine , pharmacology , superoxide dismutase , apoptosis , biology , receptor , oxidative stress , biochemistry , transcription factor , gene , serotonin
Parkinson's disease (PD) is a neurodegenerative movement disease with a high annual incidence. Accumulating evidence demonstrates that microRNAs play important roles in the pathogenesis of multiple neurological disorders, including PD. This study aims to investigate how microRNA-200a (miR-200a) regulates striatal dopamine receptor D2 (DRD2) to affect apoptosis of striatum in rats with PD and to explore the associated mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom